Gerry Smith

New York

Biotech Reporter at Bloomberg News

Biotech reporter for @business. Views are my own. Tips: [email protected]

Featured in: Favicon

bloomberg.com Favicon

uol.com.br (+1) Favicon

cnn.com

medium.com Favicon

msn.com

estadao.com.br Favicon

huffpost.com Favicon

indiatimes.com Favicon

independent.co.uk Favicon

washingtonpost.com + 95 more

Articles

RFK Jr.’s Vaccine Panel Meets in Early Test for Scientific Sway

1 week ago | news.bloombergtax.com | Gerry Smith |Damian Garde

XYour Choices Regarding Cookies and IdentifiersWe and our 150 third party partners use cookies and similar technologies ("Cookies") and hashed identifiers (e.g., a hashed version of your name, email address or phone number) to help us identify you on our site and third-party sites and to process certain information, such as your IP address and digital identifiers, to analyze site usage and provide you with relevant advertisements and content.
RFK Jr.’s Vaccine Panel Meets in Early Test for Scientific Sway

1 week ago | news.bloomberglaw.com | Gerry Smith |Damian Garde

A group of embattled government advisers will meet this week in the first major test of who controls US vaccine policy: scientific experts or Robert F. Kennedy Jr.The Advisory Committee on Immunization Practices gathers a few times a year to review data and make recommendations that determine when vaccines are given and whether they are covered by insurance. The influential group, mostly unknown outside of public health circles, normally does business with little fanfare. Robert F.
RFK Jr.’s Vaccine Panel Meets in Early Test for Scientific Sway

1 week ago | bloomberg.com | Gerry Smith |Damian Garde

A group of embattled government advisers will meet this week in the first major test of who controls US vaccine policy: scientific experts or Robert F. Kennedy Jr.The Advisory Committee on Immunization Practices gathers a few times a year to review data and make recommendations that determine when vaccines are given and whether they are covered by insurance. The influential group, mostly unknown outside of public health circles, normally does business with little fanfare.
Vaccine Makers Fall After RFK Jr. Says Some Shots Don’t Work (1)

1 week ago | news.bloombergtax.com | Gerry Smith

Shares of vaccine makers fell after US Health and Human Services Secretary Robert F. Kennedy Jr.raised doubts about the efficacy of a certain type of Covid vaccine. Novavax Inc., which is seeking full approval of a shot Kennedy said might not be effective, plunged as much as 26% Thursday, the most since July. Rivals who make a different type of vaccine also saw their shares fall, with Moderna Inc. down as much as 11% and Pfizer Inc.
Vaccine Makers Fall After RFK Jr. Says Some Shots Don’t Work

2 weeks ago | bloomberg.com | Gerry Smith

A vial of the Novavax Inc. Nuvaxovid Covid-19 vaccine. (Bloomberg) -- Shares of vaccine makers fell after US Health and Human Services Secretary Robert F. Kennedy Jr. raised doubts about the efficacy of a certain type of Covid vaccine. Novavax Inc., which is seeking full approval of a shot Kennedy said might not be effective, plunged as much as 26% Thursday, the most since July. Rivals who make a different type of vaccine also saw their shares fall, with Moderna Inc.
UAW Joins Critics Slamming RFK Jr.’s Cuts to Worker Safety Unit

2 weeks ago | claimsjournal.com | Gerry Smith

The Trump administration’s move to gut the agency tasked with ensuring workplace safety is facing intensifying pushback, including from the nation’s largest auto union and a conservative lawmaker, in one of the more prominent public fights against some of the widespread cuts last week.
UAW Joins Critics Slamming RFK Jr.’s Cuts to Worker Safety Unit

2 weeks ago | bloomberg.com | Gerry Smith

The Trump administration’s move to gut the agency tasked with ensuring workplace safety is facing intensifying pushback, including from the nation’s largest auto union and a conservative lawmaker, in one of the more prominent public fights against some of the widespread cuts last week.
US Drug Manufacturers Poised for Windfall From Trump’s Tariffs

2 weeks ago | news.bloombergtax.com | Gerry Smith |Madison Muller |Ike Swetlitz

Drug manufacturers are rushing to reshape their supply chains amid President Donald Trump’s escalating tariff threats, leading to a potential windfall for contractors that make medications in the US. Those lesser-known firms, such as Lonza Group AG, Thermo Fisher Scientific Inc. and Catalent Inc., help big pharma companies with their complex supply chains, from filling syringes and producing pills all the way to manufacturing complicated biologic drugs from scratch.
Trump’s Tariff Threat Sparks Race to Find US Drug Manufacturers

2 weeks ago | bloomberg.com | Gerry Smith |Madison Muller |Ike Swetlitz

Drug manufacturers are rushing to reshape their supply chains amid President Donald Trump’s escalating tariff threats, leading to a potential windfall for contractors that make medications in the US. Those lesser-known firms, such as Lonza Group AG, Thermo Fisher Scientific Inc. and Catalent Inc., help big pharma companies with their complex supply chains, from filling syringes and producing pills all the way to manufacturing complicated biologic drugs from scratch.
Cantor Analysts Blast RFK Jr., Warn of ‘Dangerous Territory’

3 weeks ago | news.bloombergtax.com | Gerry Smith

Cantor Fitzgerald biotech analysts slammed the leadership of Health and Human Services Secretary Robert F. Kennedy Jr., calling on the Trump administration to “re-evaluate” his role after a top vaccine official stepped down. Kennedy “is steering this country into dangerous territory based on his own whims and invalidated beliefs,” analysts Josh Schimmer and Eric Schmidt wrote. “He’s ventured far outside of his swim lane.